Chembio Diagnostics, Inc., a point-of-care diagnostics company focused on detecting and diagnosing infectious diseases, this week reported financial results for the third quarter ended September 30, 2018. The company’s patented DPP® technology [Read more]
The U.S. Department of Health and Human Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR), Biomedical Advanced Research and Development Authority (BARDA) will sponsor the advanced development of [Read more]
Illumina, Inc. announced on 15 May that it acquired Edico Genome, the leading provider of data analysis acceleration solutions for next-generation sequencing (NGS). Edico Genome’s DRAGEN® Bio-IT Platform (DRAGEN) uses field programmable [Read more]
PATH and Mologic have announced a new agreement to work together to advance a rapid diagnostic test to support treatment and elimination of Plasmodium vivax. More than 2.5 billion people worldwide are at risk of [Read more]
AntoXa Corporation has obtained a license from Defence Research & Development Canada (DRDC), an Agency of the Canadian Department of National Defence, to develop and produce an anti-ricin monoclonal antibody for sale [Read more]
AbCellera Biologics Inc. this week announced that it was awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to develop rapid countermeasures against viral outbreaks. Under DARPA’s Pandemic Prevention Platform (P3) [Read more]
Boston-based cancer company Partner Therapeutics, Inc. (PTx) has acquired the global rights to develop, manufacture, and commercialize Leukine (sargramostim) from Sanofi. Leukine is an immuno-stimulant that promotes the growth and activation of [Read more]
To enable a rapid vaccine response during a severe outbreak or pandemic, there is a pressing need for a potency test that is rapid and has sufficient sensitivity to track potency in [Read more]
An analytical technology that may impact how medical professionals predict, diagnose and treat disease has earned the Department of Energy’s Pacific Northwest National Laboratory an award for excellence in technology transfer by the Federal Laboratory [Read more]
Bavarian Nordic announced on Feb. 6 the results of a successful Phase 3 clinical trial led by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) that demonstrated the safety and [Read more]
© 2018 STEMAR MEDIA